$2.09
0.02 (+0.97%)
Corcept Therapeutics, Inc. (CORT)
CAPS Rating:
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.